FLUMIST® QUADRIVALENT (Influenza Vaccine Live ... - AstraZeneca US
Sep 23, 2022 · AstraZeneca announces FLUMIST ® QUADRIVALENT (Influenza Vaccine Live, Intranasal) doses are now available in the US for the 2022-2023 influenza season. FLUMIST QUADRIVALENT, the only Food and Drug Administration (FDA)-approved nasal-spray flu vaccine, is indicated for people ages 2 through 49. 1
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver ...
Sep 20, 2024 · FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. FluMist is sprayed into the nose and has been used...
FDA approves first flu vaccine that can be self-administered at …
Sep 20, 2024 · CNN — The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this...
No needles required: The FDA approves an at-home flu vaccine
Sep 20, 2024 · The Food and Drug Administration has approved the first flu vaccine that people can administer to themselves at home. The agency on Friday gave the green light for people who have been screened...
Nasal Flu Vaccine FluMist Gets FDA Approval for At-Home Use
Oct 4, 2024 · Recently, the Food and Drug Administration (FDA) removed those obstacles by approving the at-home use of FluMist®, an influenza vaccine administered by nasal spray. Made by AstraZeneca, FluMist will be available for home use starting in the fall of 2025. It is approved for people ages 2 through 49 (the vaccine doesn’t help prevent flu in ...
FDA Approves FluMist, an At-Home Nasal Spray Flu Vaccine - AARP
Oct 1, 2024 · The U.S. Food and Drug Administration (FDA) recently approved a nasal spray flu vaccine, called FluMist, for people ages 2 to 49 that can be ordered from an online pharmacy and administered at home.
FluMist approved for self-administration in the US
Sep 20, 2024 · FluMist has been approved in the US as the only self-administered influenza vaccine. FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1
FDA approves first self-administered flu vaccine spray - CBS News
Sep 20, 2024 · The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the...
What You Need to Know About FluMist, the Nasal Flu Vaccine - U.S. News …
Oct 26, 2024 · So, exactly what is FluMist? It is a live influenza vaccine containing a weakened flu virus for the three prominent vaccine strains. It’s approved for children as young as 2 and for adults up...
Maker of FluMist seeks to allow at-home administration of …
Oct 24, 2023 · AstraZeneca, which makes the vaccine FluMist, announced Tuesday it has submitted to the Food and Drug Administration a supplemental biologics license application that would allow for...